SEATTLE--(BUSINESS WIRE)--HerbalPharm, Inc. (Pink Sheets: HBPM - News), a Florida company ("HerbalPharm" or the "Company"), announced today that findings released from studies conducted at the Hong Kong University of Science and Technology (HKUST) on the Company's proprietary formula demonstrated that the key compound of the Company's products enables both long-term and balanced energy-level improvement by enhancing the functional capacities of the human body's vital organs. Additionally, it was determined that the key compound used in its products increases exercise endurance and performance through the strengthening of innate body conditions. ADVERTISEMENT Tests results demonstrated the additional positive effects of protecting muscles from exercise-induced damages by way of (i) enhancing the metabolism of liver glutathione and (ii) inducing the expression of heat shock proteins. Dr. Robert Ko, the Company's Co-founder and Head of Research commented, "These findings are significantly important to the legitimization of our products' efficacy. To my knowledge, no other product has shown the unique effects on anti-aging, muscle cell protection and stamina improvements." About the Company HerbalPharm, Inc. is a biotechnology company engaged in the research & development, marketing and sale of over-the-counter drugs, dietary supplements and functional beverages. The key compound used in the Company's products is based on the Company's patent pending proprietary formula of naturally occurring elements that is the result of over 15 years of research and development by one of its founding shareholders, the Hong Kong University of Science and Technology (HKUST). The compound has demonstrated, through scientific research, the ability to reverse mitochondrial decay due to aging. Mitochondrial decay is a current and popular theory as a leading cause of aging-related conditions. Scientific studies performed at HKUST have identified biochemical actions of HerbalPharm's key compound, demonstrating that it enhances the mitochondrial glutathione antioxidant status, a crucial factor in maintaining mitochondrial function and cell survival, and induces the expression of heat shock proteins, another group of important molecules for cell protection. Management's research indicates that these biochemical actions are advantageous, when compared to any other identified compounds, either synthetic or naturally occurring, in protecting important organs, including the heart, liver and brain. With its products, HerbalPharm aims to satisfy the needs of the "Baby Boomers," the heart-health and heart-disease markets and the segment of the population that is physically active. The Company has the ability to become a formidable player in the biotechnology industry. The Company has a capitalization of 28,469,298 shares of common stock issued and outstanding. Forward-Looking Statements This news release includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the Company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the Company at this time, actual results may differ materially from those described. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (1) our ability to manage the HPW acquisition and the expansion of operations; (2) our ability to obtain contracts with suppliers of raw materials and distributors of our products; (3) the risks inherent in the mutual performance of such supplier and distributor contracts (including our production performance); (4) our ability to protect and defend our proprietary technology; (5) our ability to secure and retain management capable of managing growth; (6) our ability to raise necessary financing to execute the Company's business plans; and (7) the Company's ability to comply with all applicable federal, state and local government and international rules and regulations. Corporate Services by: EquityDigest.com